Talanx (TLX) Q3 2025 earnings summary

Executive summary

• Net income for the first nine months rose 23% year-over-year to EUR 1,964 million, nearly matching the prior full-year result.

• Return on equity increased to 21.5% from 19.4% year-over-year, supported by strong technical performance and prudent large loss accounting.

• Insurance revenue remained stable at EUR 36.0 billion, with currency-adjusted growth of up to 3%.

• Diversified business model: 51% of net income from primary insurance, 49% from reinsurance.

• Combined ratio improved to 89.8% from 91.2% year-over-year.

Financial highlights

• Operating profit (EBIT) increased by 11% to EUR 4.1 billion.

• Combined ratio below 90%, the best nine-month result in company history.

• Large loss buffer of over EUR 660 million for Q4, with incurred large losses significantly below budget.

• Solvency 2 ratio at 233% as of 30 September 2025, up from 224% at 30 June 2025.

• Diluted earnings per share rose 23% to EUR 7.61.

Outlook and guidance

• Net income guidance for 2025 set above EUR 2.4 billion; 2026 target raised to approximately EUR 2.7 billion, achieving midterm goals a year early.

• Return on equity target for 2025 increased to above 19%.

• Double-digit earnings growth expected for 2026.

• Guidance assumes stable currency and capital markets and large losses within expectations; geopolitical and macroeconomic risks noted.

• Dividend policy remains "always up," with flexibility due to strong earnings.